May 29, 2019
By Sharon Rosen
Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]
Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma
January 3, 2019
Mayo Clinic discovers biological markers that could guide treatment for prostate cancer
Prostate cancer is the most common form of cancer in American men, other than skin cancer.* Statistics from the American Cancer Society show approximately 1 in 9 American men will be diagnosed with prostate cancer at some time in their lives. Mayo Clinic Center for Individualized Medicine-sponsored research released today may help families facing difficult […]
Tags: George Vasmatzis Ph.D., Gleason pattern 3 prostate cancer, John Cheville M.D., Mayo Clinic Center for Individualized Medicine, Mayo Clinic Center for Individualized Medicine Biomarker Discovery Program, Prostate Cancer
November 2, 2017
Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer. This discovery can guide health care providers to individualized treatments for castration-resistant prostate cancer, a deadly disease that does not respond to standard hormone therapy. Several U.S. Food and Drug […]
Tags: Advanced prostate cancer, castration-resistant prostate cancer, center for individualized medicine, Dr. Keith Stewart, Dr. Liewei Wang, Dr. Manish Kohli, individualized medicine, medical research, personalized medicine, Precision Medicine, Prostate Cancer, RNA sequencing
October 3, 2017
Liquid biopsies: detecting and treating cancer sooner
By Sharon Rosen
What if a blood test could discover cancer before a tumor first appears or before the first signs of cancer recurrence are seen by a radiology study? In fact, these types of blood tests, often called liquid biopsies, are already changing clinical care for patients with cancer. Researchers and physicians in Mayo Clinic Center for […]
Tags: #blood tests, #cancer treatment, #cell-free DNA testing, #CIMCon17, #circulating tumor cells, #Dr. Minetta Liu, #Individualizing Medicine 2017, #liquid biopsies, Advanced Cancer, breast cancer, cancer, cancer screening
April 29, 2016
Mayo Clinic Honored for Research Advocacy
By Jeff Briggs
Whether it’s the RIGHT Protocol, the BEAUTY breast cancer trial, or the PROMOTE prostate cancer study, the Center for Individualized Medicine is actively engaged in biomedical research. In fact, improving patient care by turning genomic research into real-world personalized medicine applications, particularly new and better genomics-based diagnostic tests, is one of the fundamental goals here. […]
Tags: beauty project, Biomedical research, breast cancer, center for individualized medicine, Dr. Charles Mayo, Dr. William Mayo, Dr. William Worrall Mayo, mayo clinic, Mayo Clinic research, PROMOTE, Prostate Cancer, Research!America
November 7, 2013
Customizing Individualized Medicine Using Tumor Genomics To Fight Prostate Cancer
By AJ Montpetit
Researchers at Mayo Clinic, and the Center for Individualized Medicine, have recently been utilizing genomic sequencing to help develop personalized care treatments for men with castration-resistant prostate cancer, a progressive and incurable stage of prostate cancer that no longer responds to hormone therapies that stop or slow testosterone production. “Men with castration-resistant prostate cancer have abysmal […]
Tags: center for individualized medicine, genome, genomics, Gianrico Farrugia, individualized medicine, Manish Kohli, mayo clinic, personalized care, personalized medicine, PROMOTE, Prostate Cancer, Prostate Cancer Medically Optimized Genome-Enhanced Therapy
October 22, 2013
Understanding Prostate Cancer, One Man At A Time
By AJ Montpetit
The Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) study uses genetic clues in castration-resistant prostate cancer (CPRC) that may identify an individualized treatment approach for men with the disease. Those with advanced prostate cancer can have tumors resistant to standard hormone treatments that lower testosterone. Our goal is to improve treatments by using genetic sequencing to uncover […]
Tags: Biopsy, cancer, castration resistent prostate cancer, castration-resistant prostate cancer, center for individualized medicine, CRPC, DNA, DNA Sequencing, genetic, Genetic Counseling, Genetic Sequencing, Genetics